![]() | |
Clinical data | |
---|---|
Trade names | Flutenal |
Other names | UR-105; Triamcinolone acetonide metembonate; 4,4'-Methylene-bis((9α-fluoro-11β,21-dihydroxy-16α,17α-isopropylidenedioxypregna-1,4-diene-3,20-dione)3-methoxy-2-naphthoate); 21,21'-[Methylenebis[(2-methoxy-1,3-naphthalenediyl)- carbonyloxy]]bis[9α-fluoro-11β-hydroxy-16α,17α-[(1-methylethylidene)- bis(oxy)]pregna-1,4-diene-3,20-dione |
Routes of administration | Topical[1] |
Drug class | Corticosteroid;Glucocorticoid |
Identifiers | |
| |
CAS Number | |
PubChemCID | |
ChemSpider | |
UNII | |
CompTox Dashboard(EPA) | |
ECHA InfoCard | 100.054.209![]() |
Chemical and physical data | |
Formula | C73H78F2O16 |
Molar mass | 1249.408 g·mol−1 |
3D model (JSmol) | |
| |
|
Flupamesone (brand nameFlutenal), also known astriamcinolone acetonide metembonate, is asyntheticglucocorticoidcorticosteroid which is marketed inSpain.[2][3][4][1] It is adimer of a C21ester oftriamcinolone acetonide.[2][3][1]